Literature DB >> 27677178

Plasmin: A Modulator of Immune Function.

Dominik F Draxler1, Maithili Sashindranath1, Robert L Medcalf1.   

Abstract

Plasmin is the effector protease of the fibrinolytic system, well known for its involvement in fibrin degradation and clot removal. However, plasmin is also recognized as a potent modulator of immunological processes by directly interacting with various cell types including leukocytes (monocytes, macrophages, and dendritic cells) and cells of the vasculature (endothelial cells, smooth muscle cells) as well as soluble factors of the immune system and components of the extracellular matrix. In fact, the removal of misfolded proteins and maintenance of tissue homeostasis seem to be major physiological functions of plasmin. However, a large body of evidence also suggests that excessive plasmin generation frequently contributes to the pathophysiology of acute and chronic inflammatory processes. Hence, one question arising from the broadening effects of plasmin in physiology is whether antifibrinolytic drugs (i.e., tranexamic acid, epsilon aminocaproic acid, or aprotinin) that target plasmin either directly or indirectly and which are commonly used to prevent or treat bleeding might have unintended consequences on the immune response or on other nonfibrinolytic processes in vivo. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27677178     DOI: 10.1055/s-0036-1586227

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  21 in total

1.  Differential expression of Plg-RKT and its effects on migration of proinflammatory monocyte and macrophage subsets.

Authors:  Barbara Thaler; Nagyung Baik; Philipp J Hohensinner; Johanna Baumgartner; Adelheid Panzenböck; Stefan Stojkovic; Svitlana Demyanets; Ihor Huk; Gersina Rega-Kaun; Christoph Kaun; Manfred Prager; Michael B Fischer; Kurt Huber; Walter S Speidl; Robert J Parmer; Lindsey A Miles; Johann Wojta
Journal:  Blood       Date:  2019-06-20       Impact factor: 22.113

2.  Soluble Urokinase Plasminogen Activator Receptor: Genetic Variation and Cardiovascular Disease Risk in Black Adults.

Authors:  Nels C Olson; Laura M Raffield; Anne H Moxley; Tyne W Miller-Fleming; Paul L Auer; Nora Franceschini; Debby Ngo; Timothy A Thornton; Ethan M Lange; Yun Li; Deborah A Nickerson; Neil A Zakai; Robert E Gerszten; Nancy J Cox; Adolfo Correa; Karen L Mohlke; Alexander P Reiner
Journal:  Circ Genom Precis Med       Date:  2021-10-28

Review 3.  Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.

Authors:  Manuel Yepes; Yena Woo; Cynthia Martin-Jimenez
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

4.  The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.

Authors:  Monika Katko; Erika Galgoczi; Annamaria Erdei; Annamaria Gazdag; Eszter Berta; Miklos Bodor; Ildiko Seres; Ildiko Hircsu; Arpad Badics; Bernadett Ujhelyi; Livia Sira; Harjit Pal Bhattoa; Endre V Nagy
Journal:  J Inflamm Res       Date:  2021-05-12

5.  Tranexamic acid is associated with selective increase in inflammatory markers following total knee arthroplasty (TKA): a pilot study.

Authors:  Andrea L Grant; Hayley L Letson; Jodie L Morris; Peter McEwen; Kaushik Hazratwala; Matthew Wilkinson; Geoffrey P Dobson
Journal:  J Orthop Surg Res       Date:  2018-06-18       Impact factor: 2.359

6.  t-PA Suppresses the Immune Response and Aggravates Neurological Deficit in a Murine Model of Ischemic Stroke.

Authors:  Dominik F Draxler; Felix Lee; Heidi Ho; Charithani B Keragala; Robert L Medcalf; Be'eri Niego
Journal:  Front Immunol       Date:  2019-03-27       Impact factor: 7.561

Review 7.  Plasmin, Immunity, and Surgical Site Infection.

Authors:  Stuart Hastings; Paul S Myles; Robert L Medcalf
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

8.  Intraoperative blood loss as indicated by haemoglobin trend is a predictor for the development of postoperative spinal implant infection-a matched-pair analysis.

Authors:  Friederike Schömig; Justus Bürger; Zhouyang Hu; Axel Pruß; Edda Klotz; Matthias Pumberger; Christian Hipfl
Journal:  J Orthop Surg Res       Date:  2021-06-18       Impact factor: 2.359

9.  Fibrinolysis and COVID-19: A plasmin paradox.

Authors:  Robert L Medcalf; Charithani B Keragala; Paul S Myles
Journal:  J Thromb Haemost       Date:  2020-07-15       Impact factor: 16.036

Review 10.  The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis.

Authors:  Yosuke Kanno
Journal:  Int J Mol Sci       Date:  2019-01-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.